About Valneva SE - ADR (VALN)
Valneva is a biotechnology company. The Company focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva serves customers in France.
- USD7.26
- USD7.30
- USD7.08
- 15.35k
Stock News
2 hours ago
Veritone, Inc. (NASDAQ:VERI) Q1 2024 Earnings Call Transcript
Yahoo
2 hours ago
Hidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar
Yahoo
2 hours ago
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Call Transcript
Yahoo
2 hours ago
Ameresco, Inc. (NYSE:AMRC) Q1 2024 Earnings Call Transcript
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
